CXCL12 and acute myeloid leukemia: Even though only a small minority of patients (<15%) shows detectable CXCL12 release during in vitro culture and most of these patients show only low release (45), increased serum CXCL12 levels have been described in patients with untreated AML, including increased levels of the cleaved active form.